Do: Respond within 15 business days of the original letter and be specific in that response. “It’s important to critically ...
Yesterday, the U.S. Food and Drug Administration (FDA) updated its website to provide new information on data integrity concerns relating to ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...
FDA took issue with the promotional communication presented in an exhibit booth panel (“panel”) [2] for Hemady ®, a drug indicated in combination with other anti-myeloma products for the treatment of ...
U.S. Secretary of Health and Human Services Robert Kennedy Jr. directed the Food and Drug Administration on Monday to revise ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and ...
Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
In the late afternoon of Feb. 26, members of the U.S. Food and Drug Administration (FDA)'s expert committee on vaccines received an unusual email. It informed them that their upcoming meeting on ...